StockNews.com Initiates Coverage on Veradigm (NASDAQ:MDRX)

Stock analysts at StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRX) in a research report issued to clients and investors on Monday. The firm set a “hold” rating on the software maker’s stock.

Veradigm Price Performance

Shares of Veradigm stock opened at $9.50 on Monday. The stock has a 50-day moving average price of $9.65 and a 200 day moving average price of $8.93. Veradigm has a 1 year low of $5.01 and a 1 year high of $14.09.

Institutional Trading of Veradigm

Institutional investors and hedge funds have recently modified their holdings of the company. Innealta Capital LLC acquired a new position in shares of Veradigm during the second quarter valued at $38,000. TFO Wealth Partners LLC increased its holdings in shares of Veradigm by 105,280.0% in the fourth quarter. TFO Wealth Partners LLC now owns 5,269 shares of the software maker’s stock worth $52,000 after acquiring an additional 5,264 shares in the last quarter. Meadow Creek Wealth Advisors LLC bought a new stake in shares of Veradigm in the first quarter worth about $83,000. Forest Hill Capital LLC acquired a new position in shares of Veradigm during the fourth quarter worth about $210,000. Finally, Campbell & CO Investment Adviser LLC boosted its position in shares of Veradigm by 5.7% during the fourth quarter. Campbell & CO Investment Adviser LLC now owns 42,113 shares of the software maker’s stock worth $442,000 after buying an additional 2,263 shares during the period.

About Veradigm

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.